Diarrhoeal and enteric infections remain a leading killer of young children globally, yet the pace of improvement has measurably slowed — a warning signal for public health investment and intervention targeting in the years ahead. Understanding exactly where and why progress has stalled matters enormously for the millions of families still bearing this preventable burden.
The GBD 2023 systematic analysis quantified incidence, mortality, and disability-adjusted life-years (DALYs) for enteric infectious diseases across 204 countries from 1990 through 2023, disaggregated by age, sex, and geography. The scope encompasses diarrhoeal diseases, enteric fever (typhoid and paratyphoid), invasive non-typhoidal Salmonella infections, and other intestinal infectious diseases, alongside 15 specific diarrhoeal aetiologies. Using Bayesian meta-regression modelling (DisMod-MR 2.1), the study provides the most granular global picture to date of these conditions' trajectory over 33 years. While headline mortality has declined substantially since 1990 — with child deaths from diarrhoeal disease falling dramatically — the rate of improvement appears to have decelerated after roughly 2015, raising serious concerns about whether the GAPPD target of fewer than 20 deaths per 100,000 children under five by 2025 will be achieved across high-burden regions.
This analysis arrives at a critical juncture. The deceleration of progress coincides with disruptions to global health infrastructure, shifting donor priorities, and the indirect impacts of the COVID-19 pandemic on routine child health services. From a longevity and population-health standpoint, early-life enteric infections carry consequences that extend well beyond acute mortality — repeated diarrheal illness in infancy is associated with stunting, cognitive deficits, and reduced adult productivity, compounding intergenerational disadvantage. The breadth of the GBD methodology — integrating surveys, hospital records, claims data, and systematic reviews — lends this estimate unusual credibility, though data sparsity in sub-Saharan Africa and South Asia introduces uncertainty intervals that deserve attention. For health-conscious audiences, the core implication is that improvements in water, sanitation, and oral rehydration access are not self-sustaining; they require continuous structural investment to hold ground, let alone accelerate.